Related references
Note: Only part of the references are listed.Synthesis and anticancer evaluation of amide derivatives of imidazo-pyridines
Chekuri Sharmila Rani et al.
MEDICINAL CHEMISTRY RESEARCH (2021)
Prevalence and significance of potential drug-drug interactions among cancer patients receiving chemotherapy
Mohammad Ismail et al.
BMC CANCER (2020)
Anthracycline-related cardiotoxicity in older patients with acute myeloid leukemia: a Young SIOG review paper
Nina Rosa Neuendorff et al.
BLOOD ADVANCES (2020)
Combination of CTLA-4 and PD-1 blockers for treatment of cancer
Anand Rotte
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2019)
The Next Generation of Immunotherapy for Cancer: Small Molecules Could Make Big Waves
William G. Kerr et al.
JOURNAL OF IMMUNOLOGY (2019)
A methanol and protic ionic liquid Ugi multicomponent reaction path to cytotoxic α-phenylacetamido amides
Ahmed Al Otaibi et al.
RSC ADVANCES (2019)
Improving combination cancer therapy: the CombiPlex((R)) development platform
Anthony W. Tolcher et al.
FUTURE ONCOLOGY (2018)
Functional Plasticity of Gamma Delta T Cells and Breast Tumor Targets in Hypoxia
Gabrielle M. Siegers et al.
FRONTIERS IN IMMUNOLOGY (2018)
Eco-friendly synthesis of novel cyanopyridine derivatives and their anticancer and PIM-1 kinase inhibitory activities
Khaled A. M. Abouzid et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2017)
Apoptosis Induced via Gamma Delta T Cell Antigen Receptor Blocking Antibodies: A Cautionary Tale
Indrani Dutta et al.
FRONTIERS IN IMMUNOLOGY (2017)
Combination therapeutics in complex diseases
Bing He et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2016)
Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
Jacques Ferlay et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
Intraperitoneal injection of in vitro expanded Vγ9Vδ2 T cells together with zoledronate for the treatment of malignant ascites due to gastric cancer
Ikuo Wada et al.
CANCER MEDICINE (2014)
Expanded human blood-derived γδT cells display potent antigen-presentation functions
Mohd Wajid A. Khan et al.
FRONTIERS IN IMMUNOLOGY (2014)
Plasticity of γδT cells: impact on the anti-tumor response
Virginie Lafont et al.
FRONTIERS IN IMMUNOLOGY (2014)
Human V2V2 T cells limit breast cancer growth by modulating cell survival-, apoptosis-related molecules and microenvironment in tumors
Reeva Aggarwal et al.
INTERNATIONAL JOURNAL OF CANCER (2013)
Combining conventional chemotherapy and γδ T cell-based immunotherapy to target cancer-initiating cells
Matilde Todaro et al.
ONCOIMMUNOLOGY (2013)
Human Neutrophil Clearance of Bacterial Pathogens Triggers Anti-Microbial γδ T Cell Responses in Early Infection
Martin S. Davey et al.
PLOS PATHOGENS (2011)
Multi-target therapeutics: when the whole is greater than the sum of the parts
Grant R. Zimmermann et al.
DRUG DISCOVERY TODAY (2007)
γδ T cells condition dendritic cells in vivo for priming pulmonary CD8 T cell responses against Mycobacterium tuberculosis
Nadia Caccamo et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2006)
Current concepts - Drug-related hepatotoxicity
VJ Navarro et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies
Ting-Chao Chou
PHARMACOLOGICAL REVIEWS (2006)
Innate anti-breast cancer immunity of apoptosis-resistant human γδ-T cells
BL Guo et al.
BREAST CANCER RESEARCH AND TREATMENT (2005)
Ex vivo expanded human Vγ9Vδ2+γδ-T cells mediate innate antitumor activity against human prostate cancer cells in vitro
ZY Liu et al.
JOURNAL OF UROLOGY (2005)
Appraisal of the MTT-based assay as a useful tool for predicting drug chemosensitivity in leukemia
T Hayon et al.
LEUKEMIA & LYMPHOMA (2003)